University of Michigan is Awarded $21 Million Grant to Study HIV Virus Behavior

Article

A $21 million grant will help researchers at the University of Michigan Health System better understand the HIV virus on a molecular level, potentially paving the way for new treatment approaches to AIDS and other diseases.

Dr. Alice Telesnitsky, professor of microbiology and immunology at the University of Michigan Medical School

A $21 million grant will help researchers at the University of Michigan Health System better understand the HIV virus on a molecular level, potentially paving the way for new treatment approaches to AIDS and other diseases.

The National Institutes of Health grant, which will be distributed during a five-year period, establishes the Center for HIV RNA Studies, or CRNA.

Alice Telesnitsky, PhD, a professor of microbiology and immunology at the U-M Medical School, will head the CRNA and says the grant brings together researchers in a variety of disciplines to tackle the sometimes tricky HIV-1 RNA molecule, which plays an essential role in a virus ability to reproduce itself.

Viruses are made up of proteins and RNA, and most research focuses on the proteins, she says. Because RNA is a simple molecule, it can sometimes appear nondescript when we look at it. This grant will unite a team of people who will look at RNA on different scales, assessing its structure, movement and replication.

Telesnitsky says a better understanding of RNAs biological processes could ultimately lead to innovative treatments for AIDS and other human diseases.

Researchers from Telesnitskys lab at U-M, as well as scientists from 13 other institutions across the country, will use the NIH grant to take a multidisciplinary approach to the research.

Telesnitsky says the team includes world leaders in fields such as structural biology, chemistry, cell and computation biology, molecular biology and virology.

Funding for the grant comes from the National Institute of General Medical Sciences and the NIHs National Institutes of Allergy and Infectious Diseases.

This is an absolutely outstanding group of structural biologists and virologists focused on an understudied yet critical component of the HIV virionthe genomic RNA, says Michael Sakalian, PhD, the NIGMS official who oversees the grant for the specialized center. Their efforts to elucidate the structural and functional roles of RNA in the viral life cycle will advance our fundamental understanding of host-virus interactions as well as identify potential new targets for therapeutic intervention.

Source: University of Michigan Health System

 

Related Videos
Patient Safety: Infection Control Today's Trending Topic for March
Infection Control Today® (ICT®) talks with John Kimsey, vice president of processing optimization and customer success for Steris.
Picture at AORN’s International Surgical Conference & Expo 2024
Infection Control Today and Contagion are collaborating for Rare Disease Month.
Rare Disease Month: An Infection Control Today® and Contagion® collaboration.
Vaccine conspiracy theory vector illustration word cloud  (Adobe Stock 460719898 by Colored Lights)
Rare Disease Month: An Infection Control Today® and Contagion® collaboration.
Infection Control Today Topic of the Month: Mental Health
Infection Control Today's topic of the month: Mental Health
Related Content